000182449 001__ 182449
000182449 005__ 20240229145719.0
000182449 0247_ $$2doi$$a10.1038/s41408-022-00728-z
000182449 037__ $$aDKFZ-2022-02658
000182449 082__ $$a610
000182449 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$udkfz
000182449 245__ $$aSurvival trends in hematological malignancies in the Nordic countries through 50 years
000182449 260__ $$aLondon [u.a.]$$bNature Publishing Group$$c2022
000182449 3367_ $$2DRIVER$$aarticle
000182449 3367_ $$2DataCite$$aOutput Types/Journal article
000182449 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1667833220_6565
000182449 3367_ $$2BibTeX$$aARTICLE
000182449 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182449 3367_ $$00$$2EndNote$$aJournal Article
000182449 500__ $$aCorrespondence
000182449 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000182449 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000182449 7001_ $$aHemminki, Janne$$b1
000182449 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b2$$udkfz
000182449 7001_ $$00000-0002-6133-0164$$aSud, Amit$$b3
000182449 773__ $$0PERI:(DE-600)2600560-8$$a10.1038/s41408-022-00728-z$$gVol. 12, no. 11, p. 150$$n11$$p150$$tBlood cancer journal$$v12$$x2044-5385$$y2022
000182449 909CO $$ooai:inrepo02.dkfz.de:182449$$pVDB
000182449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000182449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000182449 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000182449 9141_ $$y2022
000182449 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-27
000182449 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBLOOD CANCER J : 2021$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-14T16:18:54Z
000182449 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-14T16:18:54Z
000182449 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-14T16:18:54Z
000182449 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-29
000182449 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bBLOOD CANCER J : 2021$$d2022-11-29
000182449 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000182449 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000182449 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000182449 980__ $$ajournal
000182449 980__ $$aVDB
000182449 980__ $$aI:(DE-He78)C020-20160331
000182449 980__ $$aI:(DE-He78)B062-20160331
000182449 980__ $$aI:(DE-He78)HD01-20160331
000182449 980__ $$aUNRESTRICTED